Perimenopause and Thyroid: When Symptoms Overlap

DEFINITION

TSH (Thyroid-Stimulating Hormone)

TSH is the primary blood test used to screen for thyroid dysfunction. High TSH typically indicates hypothyroidism (underactive thyroid); low TSH indicates hyperthyroidism. Subclinical hypothyroidism — elevated TSH without overt symptoms — is common in women over 40 and can compound perimenopause symptoms.

DEFINITION

Hashimoto's thyroiditis

An autoimmune condition in which the immune system attacks the thyroid gland, gradually reducing its hormone output. Hashimoto's is the most common cause of hypothyroidism in women and tends to become more prevalent during the perimenopausal years. It can cause fatigue, weight gain, brain fog, mood changes, and cold intolerance — symptoms that overlap substantially with perimenopause.

DEFINITION

Subclinical hypothyroidism

A state in which TSH is elevated but thyroid hormone levels (T3, T4) remain within the normal range. Symptoms may be mild or absent, but subclinical hypothyroidism can still contribute to fatigue, weight difficulty, and mood changes. Its prevalence increases with age, particularly in women.

Why These Two Conditions Get Confused

Hypothyroidism and perimenopause produce overlapping symptom profiles. Both can cause fatigue, weight gain that feels resistant to diet changes, mood instability, difficulty concentrating, and disrupted sleep. Neither produces symptoms specific enough to be self-diagnosing from a checklist.

Management differs between the two. Hypothyroidism is treated with thyroid hormone replacement (levothyroxine). Perimenopause symptoms are managed with hormone therapy, lifestyle changes, or non-hormonal options depending on symptoms and preferences. Treating one when the other is the driver — or missing that both are present — leaves women without adequate relief.

Who Is at Highest Risk for Both

Women in their 40s and early 50s sit at the intersection of two rising prevalence curves. Autoimmune thyroid disease (predominantly Hashimoto’s) increases in frequency throughout the fourth and fifth decades of life and is significantly more common in women than men. The perimenopausal transition occurs across the same window.

Women with a personal or family history of autoimmune conditions face additional thyroid risk. Those with a history of postpartum thyroiditis are also at elevated risk for developing Hashimoto’s later in life.

Symptoms That Lean Toward Thyroid

While the overlap is real, some symptoms are more characteristic of hypothyroidism than perimenopause:

• Cold intolerance (feeling cold when others are comfortable)
• Constipation that is new or worsening
• Slowed heart rate
• Dry skin and brittle nails beyond what is typical for age
• Puffy face, particularly around the eyes
• Slowed reflexes

Hot flashes and night sweats, by contrast, are strongly associated with perimenopause and are not typical thyroid symptoms.

How Tracking Helps

Tracking symptoms longitudinally — before you have a diagnosis — provides useful context for clinical conversations. If your fatigue is constant and unrelated to cycle phase, that pattern is more consistent with thyroid dysfunction. If fatigue worsens in the week before your period and improves after, that pattern fits perimenopause better.

Cycle tracking alongside symptom tracking lets you correlate symptoms with hormonal timing. Thyroid symptoms tend to be consistent across the cycle; perimenopause symptoms often show a cyclical pattern, at least in early stages.

{/* InlineSignup */}

Getting the Right Tests

A reasonable baseline workup when new symptoms appear in your 40s includes TSH and FSH. TSH screens for thyroid dysfunction; FSH provides evidence of ovarian reserve decline. Neither test alone is definitive for perimenopause, but together they help your doctor understand whether one or both conditions are contributing.

If TSH comes back normal but you continue to have significant symptoms, a repeat test in 6-12 months is reasonable given that thyroid function can change. Anti-TPO antibodies can identify Hashimoto’s before it causes measurable TSH change.

Managing Both Simultaneously

When both conditions are confirmed, treatment for each proceeds independently. Levothyroxine for hypothyroidism and hormone therapy or symptom-specific management for perimenopause do not conflict, but there is one important interaction: oral estrogen increases thyroid-binding globulin, which can lower free thyroid hormone levels. Women on thyroid replacement who start oral HRT should have TSH rechecked 6-8 weeks after starting HRT to confirm their dose is still appropriate.

Transdermal estrogen (patches, gels) has a smaller effect on thyroid-binding globulin and may be preferable for women on levothyroxine, though this should be discussed with a prescriber rather than assumed.